| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1466939A Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base |
| 01/13/2004 | US6677476 Process for preparing R-(-) -carnitine from S-(-)-chlorosuccinic acid or from a derivative thereof |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677374 Nervous system disorders |
| 01/13/2004 | US6677373 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5H-furan-2-one |
| 01/13/2004 | US6677372 N-(3-benzofuranyl)urea-derivatives |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/13/2004 | US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677341 (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6676851 Laterally substituted curable liquid crystals |
| 01/13/2004 | CA2049162C Ortho-substituted phenylacetamides |
| 01/08/2004 | WO2004003103A1 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 01/08/2004 | WO2004003035A1 Unsaturated monomers, polymers, chemically amplified resist composition, and process of pattern formation |
| 01/08/2004 | WO2004002978A1 Refreshment capable of stimulating movement of digestive tract |
| 01/08/2004 | WO2004002977A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002975A1 PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO[2,3-b]FURAN-3-OL |
| 01/08/2004 | WO2004002953A2 Lactone compounds, for use as antioxidant agents in pharmaceutical, cosmetic or food compositions |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2003087035A8 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor |
| 01/08/2004 | WO2002053522A3 Novel estrogen receptor ligands and methods i |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia |
| 01/08/2004 | US20040006100 Administering phenylacetic acid derivative for therapy of Parkinson's disease |
| 01/08/2004 | US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490677A1 Lactone compounds, for use as antioxidant agents in pharmaceutical, cosmetic or food compositions |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2488703A1 Food and beverage product for stimulating gastrointestinal mobility |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377564A2 Transition-metal-catalyzed process for the preparation of sterically hindered n-substituted alkoxyamines |
| 01/07/2004 | EP1377551A1 Antiproliferative agents |
| 01/07/2004 | EP1377373A1 Improved method for producing unsaturated cyclic ethers |
| 01/07/2004 | EP1377366A2 Supercritical fluids or dense phase gases formed from liquid precursors |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1250330B1 Process for the preparation of 3-furoate esters and novel intermediate compounds |
| 01/07/2004 | CN1466581A Alkylxanthates and their use as pesticides |
| 01/07/2004 | CN1465568A Diazonaphthaquinone series light-heat active compound and synthesis method thereof |
| 01/07/2004 | CN1133637C Triptolide analogs and composition and use thereof |
| 01/07/2004 | CN1133633C Method for prepn. of citalopram |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/06/2004 | US6673946 By hydrogenation |
| 01/06/2004 | US6673934 4-amino-2-(1-aryloxy-ethyl)phenol compound |
| 01/06/2004 | US6673932 Primary intermediates for oxidative coloration of hair |
| 01/06/2004 | US6673818 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| 01/06/2004 | US6673788 Containing 2,2,2-trifluoro-1-oxoethyl groups |
| 01/06/2004 | US6673784 Halosubstituted acetophenones as selective herpesvirus protease inhibitors |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/06/2004 | US6673122 Compositions for dyeing keratin fibers containing para-aminophenols, dyeing process, novel para-aminophenols and process for their preparation |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1375490A1 Process for the production of 2-acetyl-2-chloro-gamma-butyrolactone |
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1375468A2 Method for removing impurities from oxidation products |
| 01/02/2004 | EP1375467A1 2-Bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof |
| 01/02/2004 | EP1374853A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374852A1 Cosmetic and/or dermatological Composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374851A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374850A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374849A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373239A1 Benzofuran derivatives |
| 01/02/2004 | EP1373238A1 Alkylxanthates and their use as pesticides |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373204A2 Heterocyclic compounds |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1373194A1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1373183A1 Permanent surface modifiers |
| 01/02/2004 | EP1373158A2 Additives for building industry obtained from by-products and process for their production |
| 01/02/2004 | EP1373142A1 Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
| 01/02/2004 | EP1372807A2 Ionic liquids as selective additives for the separation of close-boiling or azeotropic mixtures |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372645A1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/02/2004 | EP1372637A2 Premixed amiodarone parenteral solution and method for making the same |
| 01/02/2004 | EP1140819B1 Alfa-sulfenimino acid derivatives |
| 01/02/2004 | EP1140799B1 Novel propargylether derivatives |
| 01/01/2004 | US20040002597 Catalytic process for the modification of carbohydrates, alcohols, aldehydes or polyhydroxy compounds |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |